Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders W Matson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Xenotransplantation|April 22, 2021
Xenotransplantation Literature Update January/February 2021Joseph Sushil Rao, Anders W Matson, R Travis Taylor, et al.
Plos One|December 11, 2019
Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing systemAnders W Matson, Nora Hosny, Zachary A Swanson, et al.
Leukemia|June 15, 2026
Can natural killer cells cure leukemia?Frank Cichocki, Martin Felices, Anders W Matson, et al.
Xenotransplantation|September 6, 2020
3'UTR enhances hCD47 cell surface expression, self-signal function, and reduces ER stress in porcine fibroblastsNora Hosny, Anders W Matson, Ramesh Kumbha, et al.
Frontiers in Immunology|February 16, 2026
Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to induce cytotoxicityKate J Dixon, Robert Hullsiek, Sam Wang, et al.
Frontiers in Immunology|September 27, 2021
HLA-G1<sup>+</sup> Expression in GGTA1KO Pigs Suppresses Human and Monkey Anti-Pig T, B and NK Cell ResponsesJoseph Sushil Rao, Nora Hosny, Ramesh Kumbha, et al.
Frontiers in Immunology|August 5, 2024
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphomaKate J Dixon, Kristin M Snyder, Melissa Khaw, et al.
Journal for Immunotherapy of Cancer|July 25, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cellsAnders W Matson, Rob Hullsiek, Kate J Dixon, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cellsAnders W Matson, Rob H Hullsiek, Kate J Dixon, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Xenotransplantation|April 22, 2021
Xenotransplantation Literature Update January/February 2021Joseph Sushil Rao, Anders W Matson, R Travis Taylor, et al.
Plos One|December 11, 2019
Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing systemAnders W Matson, Nora Hosny, Zachary A Swanson, et al.
Leukemia|June 15, 2026
Can natural killer cells cure leukemia?Frank Cichocki, Martin Felices, Anders W Matson, et al.
Xenotransplantation|September 6, 2020
3'UTR enhances hCD47 cell surface expression, self-signal function, and reduces ER stress in porcine fibroblastsNora Hosny, Anders W Matson, Ramesh Kumbha, et al.
Frontiers in Immunology|February 16, 2026
Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to induce cytotoxicityKate J Dixon, Robert Hullsiek, Sam Wang, et al.
Frontiers in Immunology|September 27, 2021
HLA-G1<sup>+</sup> Expression in GGTA1KO Pigs Suppresses Human and Monkey Anti-Pig T, B and NK Cell ResponsesJoseph Sushil Rao, Nora Hosny, Ramesh Kumbha, et al.
Frontiers in Immunology|August 5, 2024
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphomaKate J Dixon, Kristin M Snyder, Melissa Khaw, et al.
Journal for Immunotherapy of Cancer|July 25, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cellsAnders W Matson, Rob Hullsiek, Kate J Dixon, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cellsAnders W Matson, Rob H Hullsiek, Kate J Dixon, et al.
Pageof 1